IMM got metioned in trading day summary of The Australian:
‘Which Aussie biotech is in with big pharma?
Aussie biotech Immutep has secured the backing of pharma giants Merck and Pfizer to test its cancerous tumour-fighting drug in a clinical trial.
Immutep, of market cap just $124 million, has signed an agreement with European drug companies for an early phase clinical trial to test the benefits of combining its immune-stimulating drug, eftilagimod alpha (efti) with avelumab, a targeted cancer therapy being developed by Merck and Pfizer.
Shares in the stock surged to touch two-year highs of 4.5c - up almost 10 per cent on the news.
“We feel that this new collaboration, with these industry leaders, further supports our hypothesis that there is a potentially meaningful therapeutic benefit in combining eftilagimod alpha with a checkpoint inhibitor in the treatment of cancer,” chief Mark Voigt said.’
- Forums
- ASX - By Stock
- IMM
- News: IMM Immutep Says Co Entered Into Clinical Trial Collaboration And Supply Agreement
News: IMM Immutep Says Co Entered Into Clinical Trial Collaboration And Supply Agreement, page-17
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 297652 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 7500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 267172 | 0.290 |
18 | 232142 | 0.285 |
29 | 1267072 | 0.280 |
5 | 181364 | 0.275 |
10 | 229898 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 5000 | 1 |
0.305 | 196762 | 5 |
0.310 | 57067 | 3 |
0.320 | 6090 | 1 |
0.325 | 10000 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |